RIGL RIGEL PHARMACEUTICALS INC CIK 0001034842 · last filing 4d ago · 1 insider transaction
Total flow
$87.5K
1 priced transactions
cross-source convergence Divergent 2/5 sources
Insider Funds Activist Sell Events 18 / 100 Recent disclosures · timeline Form 4 4d ago
Director · sold $87.5K
Price · RIGL Live chart by TradingView Most recent insider trade: Sold 2,500 sh @ $35.00 on Jun 22, 2026 view filing → Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
RIGL insider flow· last 30 days net -$87.5K
max $87.5K/day May 24 — buy $0 · sell $0 · net +$0 May 25 — buy $0 · sell $0 · net +$0 May 26 — buy $0 · sell $0 · net +$0 May 27 — buy $0 · sell $0 · net +$0 May 28 — buy $0 · sell $0 · net +$0 May 29 — buy $0 · sell $0 · net +$0 May 30 — buy $0 · sell $0 · net +$0 May 31 — buy $0 · sell $0 · net +$0 Jun 1 — buy $0 · sell $0 · net +$0 Jun 2 — buy $0 · sell $0 · net +$0 Jun 3 — buy $0 · sell $0 · net +$0 Jun 4 — buy $0 · sell $0 · net +$0 Jun 5 — buy $0 · sell $0 · net +$0 Jun 6 — buy $0 · sell $0 · net +$0 Jun 7 — buy $0 · sell $0 · net +$0 Jun 8 — buy $0 · sell $0 · net +$0 Jun 9 — buy $0 · sell $0 · net +$0 Jun 10 — buy $0 · sell $0 · net +$0 Jun 11 — buy $0 · sell $0 · net +$0 Jun 12 — buy $0 · sell $0 · net +$0 Jun 13 — buy $0 · sell $0 · net +$0 Jun 14 — buy $0 · sell $0 · net +$0 Jun 15 — buy $0 · sell $0 · net +$0 Jun 16 — buy $0 · sell $0 · net +$0 Jun 17 — buy $0 · sell $0 · net +$0 Jun 18 — buy $0 · sell $0 · net +$0 Jun 19 — buy $0 · sell $0 · net +$0 Jun 20 — buy $0 · sell $0 · net +$0 Jun 21 — buy $0 · sell $0 · net +$0
Institutional holders · 13F Q1 2026 vs Q4 2025 · live SEC data 5 funds hold $98.41M reported value Net accumulating(4 adding · 1 reducing)
Recent insider transactions Filed Insider Transaction Shares Price Value Signal Flags 4d ago
Jun 22, 2026
Ali-Jackson Kamil Director
2,500 $35.00 $87.5K Neutral -2
I Insider · Net insider selling F Institutional · 5 funds A Activist · — S Sell pressure · — E Events · — Institutions are accumulating (5 funds). Insiders are net sellers.
Institutions accumulating+12 Broad ownership (5 funds)+6
Convergence is a transparent heuristic sum of attributable disclosure factors — not a price target or recommendation. 8-K events are shown as context; Form 144 planned sales count against bullish conviction. Not financial advice.
Jun 22 — buy $0 · sell $87.5K · net -$87.5K May 24 Jun 22 +50%
RIGLRIGEL PHARMACEUTICALS INC